Zoetis Inc. (ZTS) fundamentals score
Zoetis Inc. is a global leader in the animal health industry, focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health.
Pharmaceutical Preparations · Healthcare · Listed on NYSE
Overall: 7.0 out of 10, Mixed fundamentals
- Growth: 4.3/10
- Profitability: 8.3/10
- Financial health: 5.9/10
- Earnings quality: 9.2/10
- Valuation: 8.9/10
Scores are calculated from Zoetis Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10